Skip to main content

Statistical analysis of serum pepsinogen I (PG I) and II (PG II) levels, PG I/PG II ratios and serum gastrin levels in a general population

Environmental Health and Preventive Medicine volume 1, Article number: 136 (1996) Cite this article

Abstract

To allow adoption of serum pepsinogen as a screening indicator of gastric cancer, serum pepsinogen I & II levels, the ratios of PG I / PG II and the serum gastrin levels in a general population were studied using 850 samples selected at random from a rural area in Japan. The collected data were analyzed statistically to determine the distribution characteristics by various categories of sex and age. The following results were obtained:

1. The distributions of PG I and PG II, the ratios of PG I/PG II and serum gastrin values largely deviated from the normal distribution. Therefore, the use of non-parametrical methods was recommended for analysis of these data.

2. Although no significant difference between all selected men and all selected women was observed in any of the three parameters of PG I and PG II levels and the ratios of PG I / PG II, a significant difference between men and women was observed for PG I levels in under-fifty age groups. On the other hand, the median serum gastrin value (92.0 pg/ml) in all selected men was significantly lower than that (101.0 pg/ml) in all selected women. A statistically significant difference between men and women was observed in serum gastrin levels both in the under-forty age group and in the sixty and over age group.

3. No significant difference was observed in the pattern of changes in PG I levels with increasing age in either men or women. While PG II levels in men varied irregularly with advancing age, PG II levels in women showed obvious increases with advancing age. The ratios of PG I / PG II showed a tendency to decrease with advancing age in both men and women. Conversely, serum gastrin levels increased with advancing age in both men and women.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Miki K, Ichinose M, Ishikawa KB, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84: 1086–90.

    PubMed  CAS  Google Scholar 

  2. Watanabe C, Sumii K, Haruma K, et al. An evaluation of gastric cancer mass survay using serum pepsinogen I and II test in local inhabitants. Jpn J Gastroenterol Mass Surv 1990;89: 92–7. (in Japanese)

    Google Scholar 

  3. Aoki K, Misumi J, Goto T, et al. Comparative study of serum pepsinogen method and indirect X-ray method for gastric cancer screening. J OitaMedAss 1994;13: 27–35. (in Japanese)

    Google Scholar 

  4. Hisamichi S. Screening for gastric cancer. World J Surg 1989;13: 31–7.

    PubMed  Article  CAS  Google Scholar 

  5. Kampschoer GHM, Fujii A, Masuda Y. Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection. Scand J Gastroenterol 1989;24: 813–7.

    PubMed  Article  CAS  Google Scholar 

  6. Murata I, Clot JP, Sakabe T. Dépistage précoce du cancer de l’estomac au Japon. J Chir (Paris) 1987;124: 35–8.

    CAS  Google Scholar 

  7. Tsuji I, Fukao A, Sugawara N, Shoji T, Kuwajima I, Hisamichi S. Costeffectiveness analysis of screening for gastric cancer in Japan. Tohoku J ExpMed 1991;164: 279–84.

    Article  CAS  Google Scholar 

  8. Suemasu K (Sv). In: Disease Control Div. Health Service Bureau, The Ministry of Health and Welfare, editor. Cancer Statistics in 1990 in Japan. Tokyo: Sougou-igaku-sha, 1990: 13–4, 65-8, 107-9. (in Japanese)

    Google Scholar 

  9. Hisamichi S, Doi H, Iwasaki M, et al. Results of gastric mass survey in all Japan in the fiscal year 1989. Jpn J Gastroenterol Mass Surv 1991;92: 150–8. (in Japanese)

    Google Scholar 

  10. 10)Miki K. Gastric mass-screening for workers by serum pepsinogen method. Therapy 1992;74: 871–7. (in Japanese)

    Google Scholar 

  11. Maruyama T, Noda Y, Kumamoro Y, et al. Estimation of frequency, population doses and stochastic risks in stomach mass screening examinations in Japan, 1980. Nippon Act Radiol 1987;47: 971–82. (in Japanese)

    CAS  Google Scholar 

  12. Doi H. Accuracy and positive rates of indirect X-ray mass screening. Jpn J Gastroenterol Mass Surv 1989;84: 133–5. (in Japanese)

    Google Scholar 

  13. Nishizawa M. An outlook of gastric mass screening (2nd report) Comparison between detectability rate and morbidity rate in gastric mass screening. Jpn J Gastroenterol Mass Surv 1988;78: 100–3. (in Japanese)

    Google Scholar 

  14. Varis K, Kekki M, Harkonen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991;26 (suppl 186): 117–23.

    Article  Google Scholar 

  15. Department of the Health and Social Welfare Service for the Aged, Minister's Secretariat, The Ministry of Health and Welfare, editor. Health Maps in Cities, Towns and Villages of Japan. Tokyo: Health and Health Promotion Agency, 1989: 183. (in Japanese) 16) Norusis MJ. SPSS for Windows / Base System User's Guide, Release 6.0. Chicago: SPSS Inc., 1993: 185–6.

  16. Aoki K, Misumi J. Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area. Jpn J Public Health 1993;40: 313–22. (in Japanese)

    CAS  Google Scholar 

  17. Stemmermann GN, Samloff IM, Nomura AMY, Heilbrun LK. Serum pepsinogens I and II and stomach cancer. Clin Chim Acta 1987;163: 191–8.

    PubMed  Article  CAS  Google Scholar 

  18. Westerveld BD, Pals G, Lamers CBHW, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987;59: 952–8.

    PubMed  Article  CAS  Google Scholar 

  19. Kikuchi S, Inaba Y, Wada O, Miki K, Tenjin H, Kaneko E, Mizukoshi H. Should age, sex, subjective symptoms in the stomach and past history of peptic ulcer be regarded in the evaluation of efficacy of serum pepsinogen values for use in gastric cancer mass-screening? J Epidemiol 1993;3: 71–6.

    Google Scholar 

  20. Kikuchi S, Wada O, Miki K, et al. Serum pepsinogen as a new marker for gastric cancinoma among young adults. Cancer 1994;73: 2695–702.

    PubMed  Article  CAS  Google Scholar 

  21. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol 1988;90: 442–5.

    PubMed  CAS  Google Scholar 

  22. Kabuto M, Imai H, Tsugane S, Watanabe S. Correlation between atrophic gastritis prevalence and gastric cancer mortality among middleaged men in 5 areas in Japan. J Epidemiol 1993;3: 35–9.

    Google Scholar 

  23. Kekki M, Samloff IM, Sipponen P, Ihamäki T, Siurala M. Increase of serum pepsinogen I with age in females with normal gastric mucosa but not in males, possibly due to increase in acid-pepsin secreting area. Scand J Gastroenterol 1991;26 (suppl 186): 62–4.

    Article  Google Scholar 

  24. Yamaguchi N, Hayashi K, Chung SM, et al. Comparison of the levels of serum pepsinogen I and II between Chinese and Japanese in rural area. J Kyoto Pref Univ Med 1987;96: 1121–6.

    Google Scholar 

  25. Peyre S, Di Napoli A, Pelissero A, Sategna-Guidetti C. Diagnostic usefulness of serum group I pepsinogen determination. Gastroenterol Clin Biol 1983;7: 793–8.

    PubMed  CAS  Google Scholar 

  26. Plebani M, Di Mario F, Vianello F, et al. Actual role of pepsinogen group I in the study of upper gastrointestinal diseases. Clin Biochem 1983;16:310–2.

    PubMed  Article  CAS  Google Scholar 

  27. Korman MG, Strickland RG, Hansky J. Serum gastrin in chronic gastritis. Br Med J 1971;2: 16–8.

    PubMed  CAS  Article  Google Scholar 

  28. McGuigan JE, Trudeau WL. Serum gastrin concentrations in pernicious anemia. N Engl J Med 1970;282: 358–61.

    PubMed  CAS  Google Scholar 

  29. Nakanome C, Yamazaki H, Sasaki M, Tanno N, Sato W, Moriai N, Komatsu K. Serum group I pepsinogen (PG I ) levels in the subjects with endoscopically normal mucosa and the patients with peptic ulcer. Jpn J Gastroenterol 1983;80: 2181–7. (in Japanese)

    CAS  Google Scholar 

  30. Noguchi M, Nakajima K, Yoshii M, et al. Clinical significance of serum group I pepsinogen level in gastric duodenal diseases. Jpn J Gastroenterol 1983;80: 131–9. (in Japanese)

    CAS  Google Scholar 

  31. Pals G, Defize J, Pronk JC, Frants RR, Eriksson AW. Relations between serum pepsinogen levels, pepsinogen phenotypes, ABO blood groups, age and sex in blood donors. Ann Hum Biol 1985;12: 403–11.

    PubMed  Article  CAS  Google Scholar 

  32. Oka H, Miki K, Miyoshi S, et al. Clinical application of pepsinogen RIAkits. Clin Adult Diseases 1989;19: 531–7. (in Japanese)

    Google Scholar 

  33. Miki K, Oka H. Significance of serum pepsinogen determination. Intern Med 1986;58: 716–8. (in Japanese)

    Google Scholar 

  34. Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982;83: 204–9.

    PubMed  CAS  Google Scholar 

  35. Miki K, Ichinose M. Chronic atrophic gastritis and serum pepsinogen levels. Jpn J Cancer Clin 1992;38: 221–9. (in Japanese)

    Google Scholar 

  36. Ichinose M, Miki K, Furihata C, et al. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982;126: 183–91.

    PubMed  Article  CAS  Google Scholar 

  37. Miki K. Pepsinogen. Intern Med 1988;61: 1055. (in Japanese)

    Google Scholar 

  38. Strickland RG, Korman MG, Hansky J. Gastrin, age and the gastric mucosa. Aust NZ J Med 1973;3: 152–6.

    CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Public Health and Hygiene, Faculty of Medicine, Oita Medical University, Oita

    Kazuo Aoki & Junichi Misumi

Authors
  1. Kazuo Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Junichi Misumi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kazuo, A., Junichi, M. Statistical analysis of serum pepsinogen I (PG I) and II (PG II) levels, PG I/PG II ratios and serum gastrin levels in a general population. Environ Health Prev Med 1, 136 (1996). https://doi.org/10.1007/BF02931205

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1007/BF02931205

Keywords

  • Serum pepsinogen
  • Serum gastrin
  • General population
  • Gastric cancer screen-